Elrashdy Moustafa Mohamed Redwan, Elrashdy M M Redwan, El-Rashdy M Mohamed, El Rashdy Mohamed
Also known as: Elrashdy M. Redwan, Elrashdy Moustafa Mohamed Redwan, Elrashdy M M Redwan, El-Rashdy M Mohamed, El Rashdy Mohamed, Mohamed Redwan Elrashdy moustafa, Moahmed Redwan Elrashdy:King Abdulaziz University, Jeddah, Saudi Arabia
King Abdulaziz University
Research areas: Medicine · Infectious Diseases · SARS-CoV-2 and COVID-19 Research · COVID-19 Clinical Research Studies · Protein Structure and Dynamics
0000-0001-8246-0075
About
Elrashdy M Redwan: is a Ph.D. Professor, he obtained his Master's and Ph.D. in biomedicine (Comparative Immunology and Immunology, respectively) from Cairo University of Egypt (1995) and was promoted to a permanent senior researcher position at the Department of Biomedical Research, VACSERA, where he conducted research on viral and bacterial vaccine development and vaccine immunology. In 1998, he was nominated for a permanent professorship at the City for Scientific Research and Technology Applications (New Borg Alrab, Alexandria 21934, Egypt), where he established his Laboratory of the Protective and Therapeutic Proteins within the Protein Research Department. For two years, Prof. Redwan worked as visiting scientist at the Scripps Research Institute (TSRI, San Diego) on monoclonal antibody humanization and crystallization. Over the past 20 years, Prof. Redwan has focused his scientific research on the topics related to life-treating infectious diseases, such as enteric pathogens, Haemophilus influenzae type B virus (HIb), hepatitis C virus (HCV), and hepatitis B virus (HBV). He also looks for roles of natural products as potential anti-viral and anti-bacterial alternative medicine. Prof. Redwan has established a cluster of platforms for the production of new biopharmaceuticals and/or biosimilars. Over the years, he supervised and trained many Ph.D. and Master's Degree students, as well as Postdoctoral Fellows in the fields of immunology and infectious diseases. Prof. Redwan published many scientific articles and book chapters, served as an editor and reviewer for many academic journals, and worked as a Guest Professor in several national and foreign universities and institutes. He served as an expert in national organizations, such as the Egyptian Academy of Scientific Research and Technologies. Prof. Redwan received many national academic honors (2008, 2009, 2010). Currently, he is a Sabbaticals Professor at Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia.
Employment
-
King Abdulaziz University Professor2011 - Present
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (234)
- The Mucin Paradox: Decoding the Molecular Strategies of Akkermansia muciniphila in Health and Disease Save
- Beyond correlation and causation: epistemic caution, anomalous findings, and COVID-19 vaccine safety Save
- The Tissue-Dependent Role of Akkermansia muciniphila in Stress-Associated Breast Cancer: Integrating Microbiota and Psycho-Oncological Care Save
- The intrinsic potential of IgY–polymyxin B nanocombinations for combating colistin-resistant Salmonella enterica serovar Typhimurium isolated from ready-to-cook chicken Save
- Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990-2023: a Global Burden of Disease study. Save
- Molecular genomic insights into melanoma associated proteins PRAME and BAP1 Save
- Intrinsic disorder angle of the HCV co-infection and super-infection with other hepatitis viruses Save
- New Neonatal and Prenatal Approach to Home Therapy with Amoxicillin, Rifaximin, and Anti-Inflammatory Drugs for Pregnant Women with COVID-19 Infections—Monitoring of Fetal Growth as a Prognostic Factor: A Triple Case Series (N.A.T.H.A.N.) Save
- The XEC Variant: Genomic Evolution, Immune Evasion, and Public Health Implications Save
- Intrinsic Factors Behind Long COVID: VI. Combined Impact of G3BPs and SARS‐CoV‐2 Nucleocapsid Protein on the Viral Persistence and Long COVID Save
- Does SARS-CoV-2 Possess “Allergen-Like” Epitopes? Save
- Exploring Anticitrullinated Antibodies (ACPAs) and Serum-Derived Exosomes Cargoes Save
- Global burden of vision impairment due to age-related macular degeneration, 1990-2021, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021 Save
- Global, regional, and national progress towards the 2030 global nutrition targets and forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Save
- Interplay between Multisystem Inflammatory Syndrome in Children, Interleukin 6, Microbiome, and Gut Barrier Integrity Save
- Interplay between Comorbidities and Long COVID: Challenges and Multidisciplinary Approaches Save
- Global pattern, trend, and cross-country inequality of early musculoskeletal disorders from 1990 to 2019, with projection from 2020 to 2050. Save
- Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021. Save
- Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Save
- Unveiling the genetic tapestry: Rare disease genomics of spinal muscular atrophy and phenylketonuria proteins. Save